We suggest that glucocorticoids may influence breast cancer behavior via the upregulation of clusterin, which might play a major role in the effects of dexamethasone, protecting breast cancer cells from the effects of both paclitaxel and doxorubicin. The gene discussed is CLU; the disease is breast cancer.